Hengrui Pharmaceuticals Expands Presence with Cytokinetics Deal
Hengrui Pharmaceuticals, a leading Chinese drug developer, has made significant strides in the global biopharmaceutical landscape by out-licensing a promising candidate to Cytokinetics, a California-based biotechnology company. This latest agreement…